Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Feasibility of REBOA-Resuscitative Endovascular Balloon Occlusion of the Aorta-in Trauma-Related Noncompressible Torso Hemorrhage at Two Metropolitan Trauma Centers.

Ryan G, Swift K, Williamson F, Scriven E, Zheng O, Eley R.

Ochsner J. 2018 Fall;18(3):201-203. doi: 10.31486/toj.18.0025. No abstract available.

2.

A Prospective Before and After Study of Droperidol for Prehospital Acute Behavioral Disturbance.

Page CB, Parker LE, Rashford SJ, Bosley E, Isoardi KZ, Williamson FE, Isbister GK.

Prehosp Emerg Care. 2018 Mar 20:1-9. doi: 10.1080/10903127.2018.1445329. [Epub ahead of print]

PMID:
29558224
3.

Advance care planning uptake among patients with severe lung disease: a randomised patient preference trial of a nurse-led, facilitated advance care planning intervention.

Sinclair C, Auret KA, Evans SF, Williamson F, Dormer S, Wilkinson A, Greeve K, Koay A, Price D, Brims F.

BMJ Open. 2017 Feb 24;7(2):e013415. doi: 10.1136/bmjopen-2016-013415.

4.
5.

Prospective evaluation of tools to assess the psychological response of CPR provision to a relative who has suffered a cardiac arrest: a pilot project.

Nunnink L, Williamson F, Broome A, McNeill I.

Resuscitation. 2011 Feb;82(2):160-6. doi: 10.1016/j.resuscitation.2010.09.476. Epub 2010 Nov 10.

PMID:
21067857
6.

Depressive symptomatology in young people with Gilles de la Tourette Syndrome-- a comparison of self-report scales.

Robertson MM, Williamson F, Eapen V.

J Affect Disord. 2006 Apr;91(2-3):265-8. Epub 2006 Feb 7.

PMID:
16464507
7.

Heparinase-II-catalysed degradation of N-propionylated heparin.

Moffat CF, Long WF, McLean MW, Williamson FB.

Biochem Soc Trans. 1997 Nov;25(4):S654. No abstract available.

PMID:
9450082
8.

The effect of desferrioxamine on the development of renal dysfunction in streptozotocin-induced diabetes.

Whiting PH, Jiffri E, Thomson L, Beaton W, Williamson FW, Long WF.

Biochem Soc Trans. 1997 Nov;25(4):S570. No abstract available.

PMID:
9449998
9.

Heparinase-II-catalyzed degradation of N-propionylated heparin.

Moffat CF, Long WF, McLean MW, Williamson FB.

Arch Biochem Biophys. 1997 Feb 15;338(2):201-6.

PMID:
9028872
10.

The binding of platinum (II) to heparin.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1996 May;24(2):204S. No abstract available.

PMID:
8736862
11.

Similarity and dissimilarity in aspects of the binding to heparin of Ca2+ and Zn2+ as revealed by potentiometric titration.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1996 May;24(2):203S. No abstract available.

PMID:
8736861
12.

The antioxidant activity of heparins.

Grant D, Long WF, Mackintosh G, Williamson FB.

Biochem Soc Trans. 1996 May;24(2):194S. No abstract available.

PMID:
8736852
13.

Heparin inhibits production of thiobarbituric acid-reactive substances in the the presence of linolenic acid and Fe2+ ions.

Ross MA, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Nov;20(4):364S. No abstract available.

PMID:
1487025
14.

Complexation of Zn2+ ions by heparin.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Nov;20(4):363S. No abstract available.

PMID:
1487024
15.

Evidence from potentiometric titration for lack of reversibility in the interaction between heparin and Cu2+ or Ca2+ ions.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Nov;20(4):362S. No abstract available.

PMID:
1487023
16.

Complexation of Fe2+ ions by heparin.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Nov;20(4):361S. No abstract available.

PMID:
1487022
17.

The effect of heparin on the u.v. absorption properties of Fe(II) and Fe(III).

Williamson MF, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Nov;20(4):360S. No abstract available.

PMID:
1487021
18.

Zn(2+)-heparin interaction studied by potentiometric titration.

Grant D, Long WF, Williamson FB.

Biochem J. 1992 Nov 1;287 ( Pt 3):849-53.

19.

Inhibition by heparin of Fe(II)-catalysed free-radical peroxidation of linolenic acid.

Ross MA, Long WF, Williamson FB.

Biochem J. 1992 Sep 15;286 ( Pt 3):717-20.

20.

A potentiometric titration study of the interaction of heparin with metal cations.

Grant D, Long WF, Williamson FB.

Biochem J. 1992 Jul 15;285 ( Pt 2):477-80.

21.
22.

Effect of chemically modified heparins, and of heparin fragments, on Fe(II)-catalyzed peroxidation of linolenic acid.

Ross MA, Long WF, Williamson FB, Moffat CF.

Biochem Soc Trans. 1992 May;20(2):216S. No abstract available.

PMID:
1397589
23.

Examination of cation-heparin interaction by potentiometric titration.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1992 May;20(2):215S. No abstract available.

PMID:
1397588
24.

13C-n.m.r. spectroscopy of Cu(2+)-heparin suggests phase separation of the complex from Cu2+ in aqueous solution.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1992 May;20(2):214S. No abstract available.

PMID:
1397587
25.
26.

Cu(2+)-heparin interaction studied by polarimetry.

Grant D, Long WF, Moffat CF, Williamson FB.

Biochem J. 1992 Apr 1;283 ( Pt 1):243-6.

27.

A study of Ca(2+)-heparin complex-formation by polarimetry.

Grant D, Long WF, Moffat CF, Williamson FB.

Biochem J. 1992 Mar 1;282 ( Pt 2):601-4.

28.

Extraction of a calcification inhibitor from Corallina officinalis.

Somers JA, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Feb;20(1):5S. No abstract available.

PMID:
1633974
29.

Multiple-specular-reflectance i.r. spectroscopy of glycosaminoglycan-cetylpyridinium complexes.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Feb;20(1):4S. No abstract available.

PMID:
1633965
30.

Decrease in carboxylate absorption during heparin-poly L-lysine interaction.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Feb;20(1):3S. No abstract available.

PMID:
1633959
31.

Polarimetry of mixtures of Cu(II) ions and chemically modified heparins.

Grant D, Long WF, Moffat CF, Williamson FB.

Biochem Soc Trans. 1992 Feb;20(1):2S. No abstract available.

PMID:
1633945
32.

The effect of Cu(II) ions on the optical rotation of heparin.

Grant D, Long WF, Moffat CF, Williamson FB.

Biochem Soc Trans. 1992 Feb;20(1):1S. No abstract available.

PMID:
1633933
33.

Patterns of angiogenic response to mast cell granule constituents.

Duncan JI, Brown FI, McKinnon A, Long WF, Williamson FB, Thompson WD.

Int J Microcirc Clin Exp. 1992 Feb;11(1):21-33.

PMID:
1372883
34.

Heparin reduces Fe(II)-catalyzed peroxidation of linolenic acid.

Ross MA, Long WF, Williamson FB.

Biochem Soc Trans. 1992 Feb;20(1):6S. No abstract available.

PMID:
1321761
35.

Heparinase II from Flavobacterium heparinum. HPLC analysis of the saccharides generated from chemically modified heparins.

Moffat CF, McLean MW, Long WF, Williamson FB.

Eur J Biochem. 1991 Dec 5;202(2):531-41.

36.

I.r. spectroscopic analysis of heparin-polypeptide interaction.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1991 Nov;19(4):395S. No abstract available.

PMID:
1794526
37.

Carboxylate symmetric stretching frequencies and optical rotation shifts of heparin-cation complexes.

Grant D, Moffat CF, Long WF, Williamson FB.

Biochem Soc Trans. 1991 Nov;19(4):394S. No abstract available.

PMID:
1794525
38.

Optical rotation changes in chemically modified heparins as a guide to anionic groups involved in Ca2+ binding.

Grant D, Moffat CF, Long WF, Williamson FB.

Biochem Soc Trans. 1991 Nov;19(4):393S. No abstract available.

PMID:
1794524
39.

A relationship between cation-induced changes in heparin optical rotation and heparin-cation association constants.

Grant D, Moffat CF, Long WF, Williamson FB.

Biochem Soc Trans. 1991 Nov;19(4):392S. No abstract available.

PMID:
1794523
40.

Ca(2+)-heparin interaction investigated polarimetrically.

Grant D, Moffat CF, Long WF, Williamson FB.

Biochem Soc Trans. 1991 Nov;19(4):391S. No abstract available.

PMID:
1794522
41.

N.m.r. spectroscopy of Ca(2+)-heparin suggests delocalized binding of the cation.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1991 Nov;19(4):390S. No abstract available.

PMID:
1794521
43.

Heparinase II from Flavobacterium heparinum. Action on chemically modified heparins.

Moffat CF, McLean MW, Long WF, Williamson FB.

Eur J Biochem. 1991 Apr 23;197(2):449-59.

44.
45.

The dependence on counter-cation of the degree of hydration of heparin.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1990 Dec;18(6):1283-4. No abstract available.

PMID:
2088921
46.

Iduronate residue ring conformations in heparan sulphates of normal and transformed fibroblasts.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1990 Dec;18(6):1282-3. No abstract available.

PMID:
2088920
47.

A possible ring conformational change of iduronate residues detected by i.r. spectroscopy of aqueous solutions of lithium-heparin.

Grant D, Long WF, Williamson FB.

Biochem Soc Trans. 1990 Dec;18(6):1281-2. No abstract available.

PMID:
2088919
48.

Effect of chemical reduction of the iduronate of heparin on i.r. absorption bands sensitive to sugar conformation.

Grant D, Long WF, Moffat CF, Williamson FB.

Biochem Soc Trans. 1990 Dec;18(6):1279-80. No abstract available.

PMID:
2088918
49.

Infrared spectroscopy as a method for investigating the conformations of iduronate saccharide residues in glycosaminoglycans.

Grant D, Long WF, Moffat CF, Williamson FB.

Biochem Soc Trans. 1990 Dec;18(6):1277-9. No abstract available.

PMID:
2088917
50.

Supplemental Content

Loading ...
Support Center